Drug recall · May 8, 2019
GlipiZIDE Extended-release Tablets recall
Why: Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
- Lots / codes
Lot # 181288, EXP 5/31/2020
- Quantity
- 2,203 cartons (cartons of 30 individual unit doses)
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- April 8, 2019 · Voluntary: Firm initiated
- Classified
- May 10, 2019
- Reported
- May 8, 2019
- Ended
- November 6, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glipizide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.